Evidence map›Paper›PMID 41485087›Full record

ArticleCell communication and signaling : CCS2026

CAPNS1/Dicer feedback loop facilitates glycolysis, proliferation, and metastasis in hepatocellular carcinoma cells by inhibiting the maturation of MicroRNA pool.

Zhirui Zeng, Dahuan Li, Shan Lei, Xin Bao, Wanyuan Ruan, Qianting Tian, Wenjing Tang, Huading Tai, Xiaomin Zhang, Chujiao Hu and 2 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zhirui Zeng *Engineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Dahuan Li *Engineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Shan Lei *Engineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Xin Bao *Engineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Wanyuan RuanEngineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Qianting TianEngineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Wenjing TangEngineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Huading TaiEngineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Xiaomin ZhangEngineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China.
Chujiao HuState Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, 550009, China. huchujiao2021@gmc.edu.cn.
Yunhuan ZhenDepartment of Colorectal Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550009, China. yunhuanzhen72@163.com.
Tengxiang ChenEngineering Research Center of Chronic Disease Diagnosis and Treatment, School of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 550009, China. txch@gmc.edu.cn.

Funding

Discipline Leading Talents Project of the Affiliated Hospital of Guizhou Medical University No.gyfyxkyc-2023-01the Continuous Support Fund for Excellent Scientific Research Platform of Colleges and Universities in Guizhou Province (QJJ (2022) 020the National Nature Science Foundation of China NO.82303903The Science and Technology Planning Project of Guizhou Province Qianke Science Support[2023]General 191
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the common malignancy in digestive system, characterized by glucose metabolic reprogramming, which supplies the necessary nutrients and energy to sustain significantly increased cell proliferation and metastasis. However, the underlying mechanistic connections between glycolysis and HCC cells have not been comprehensively elucidated. Herein, through whole-gene CRISPR library screen, Calpain S1 (CAPNS1) was considered a key gene that significantly promotes cell proliferation under conditions where cells rely solely on glycolytic metabolism. Higher CAPNS1 levels were found in HCC tissues, correlating with increased glycolysis level, advanced tumor stage, and shorter survival days. CAPNS1 overexpression enhanced glycolysis, proliferation, and metastasis of HCC cells, whereas CAPNS1 knockdown produced inverse effects. CAPNS1 interacted with calpain 2 to form heterodimers, bound to Dicer, and cleaved Dicer at the arginine 1910 site, thereby suppressing the maturation of various microRNAs, such as miR-200a-3p and miR-122-5p, which targeting enzymes of glycolysis. The lactate produced from glycolysis increased H3K27 acetylation at the promoter region of CAPNS1, thereby enhancing CAPNS1 transcription. Taken together, the CAPNS1/Dicer feedback loop facilitated glycolysis, proliferation, and metastasis in HCC cell by inhibiting the maturation of the microRNA pool. Consequently, CAPNS1 may represent as a remarkable biomarker and therapic target for HCC.

Indexed as

Carcinoma, HepatocellularDEAD-box RNA HelicasesFeedback, PhysiologicalGlycolysisLiver NeoplasmsMicroRNAsRibonuclease IIICell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansMetabolic ReprogrammingNeoplasm MetastasisDEAD-box RNA HelicasesDICER1 protein, humanMicroRNAsRibonuclease IIICalpain S1DicerGlycolysisHepatocellular carcinomaMicroRNA pool

Identifiers

PMID41485087
PMCPMC12866461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.